Laurie H Sehn Selected Research

Paraffin

9/2015	Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies.
9/2012	A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma.
10/2008	Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.
6/2008	Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurie H Sehn Research Topics

Disease

57	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2024 - 08/2005
28	Neoplasms (Cancer) 02/2024 - 06/2007
27	Lymphoma (Lymphomas) 02/2024 - 04/2005
21	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2023 - 09/2011
17	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2024 - 05/2007
9	Hodgkin Disease (Hodgkin's Disease) 11/2022 - 08/2010
6	B-Cell Lymphoma (Lymphoma, B Cell) 03/2024 - 03/2009
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 05/2012
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022 - 01/2012
4	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 08/2014
4	Disease Progression 01/2022 - 06/2015
3	Neutropenia 01/2018 - 06/2015
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 12/2023 - 01/2022
2	Febrile Neutropenia 01/2018 - 06/2015
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2017 - 06/2013
1	Plasmablastic Lymphoma 10/2022
1	Infections 01/2022
1	COVID-19 01/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2020
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2020
1	Residual Neoplasm 01/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2019
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2018
1	Hypoalbuminemia 12/2017
1	Erythema elevatum diutinum 01/2017
1	Thrombocytopenia (Thrombopenia) 08/2016
1	Cough 10/2015

Drug/Important Bio-Agent (IBA)

66	Rituximab (Mabthera)FDA Link 04/2024 - 08/2005
33	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2024 - 08/2005
32	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2024 - 08/2005
31	Prednisone (Sone)FDA LinkGeneric 04/2024 - 08/2005
31	Vincristine (Oncovin)FDA LinkGeneric 12/2023 - 08/2005
14	obinutuzumabIBA 09/2023 - 05/2012
9	Bendamustine Hydrochloride FDA Link 12/2023 - 08/2016
8	polatuzumab vedotinIBA 04/2024 - 06/2015
8	Biomarkers (Surrogate Marker)IBA 02/2024 - 06/2011
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2007
5	Monoclonal AntibodiesIBA 01/2022 - 04/2005
4	GalliumIBA 11/2023 - 01/2019
4	ibrutinibIBA 01/2023 - 01/2019
4	ParaffinIBA 09/2015 - 06/2008
3	AnthracyclinesIBA 12/2023 - 01/2008
3	Lenalidomide (CC 5013)FDA Link 10/2022 - 01/2017
3	carboxyl radical (COO-)IBA 11/2021 - 09/2015
3	Dacarbazine (DIC)FDA LinkGeneric 01/2021 - 09/2012
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 09/2012
3	Vinblastine (Vinblastine Sulfate)FDA Link 01/2021 - 09/2012
3	Methotrexate (Mexate)FDA LinkGeneric 10/2019 - 06/2015
2	thiamine triphosphorate (TTP)IBA 03/2024 - 06/2014
2	Indicators and Reagents (Reagents)IBA 01/2023 - 09/2015
2	Circulating Tumor DNAIBA 11/2022 - 01/2022
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2017
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 06/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2017
2	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 06/2015
2	venetoclaxIBA 01/2021 - 01/2019
2	R-CHOP protocolIBA 10/2016 - 10/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2014 - 01/2010
2	MicroRNAs (MicroRNA)IBA 08/2013 - 06/2011
1	Bispecific AntibodiesIBA 03/2024
1	Complement System Proteins (Complement)IBA 11/2022
1	Glucose (Dextrose)FDA LinkGeneric 05/2022
1	tixagevimabIBA 01/2022
1	ElementsIBA 01/2022
1	bamlanivimabIBA 01/2022
1	casirivimab and imdevimab drug combinationIBA 01/2022
1	sotrovimabIBA 01/2022
1	cilgavimabIBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	Alkylating AgentsIBA 01/2022
1	NucleotidesIBA 10/2021
1	AntigensIBA 01/2020
1	LigandsIBA 12/2019
1	pinatuzumab vedotinIBA 05/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	ChromatinIBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 10/2018
1	1-methyl-4-(1-naphthylvinyl)piperidine (B 120)IBA 01/2018
1	Genetic Markers (Genetic Marker)IBA 01/2017
1	Guanosine Diphosphate (GDP)IBA 01/2017
1	Gemcitabine FDA Link 01/2017
1	Formaldehyde (Formol)FDA Link 09/2015
1	DNA (Deoxyribonucleic Acid)IBA 09/2015
1	Ifosfamide FDA LinkGeneric 06/2015
1	Immunoconjugates (Immunoconjugate)IBA 06/2015

Therapy/Procedure

39	Therapeutics 12/2023 - 04/2005
28	Drug Therapy (Chemotherapy) 03/2024 - 06/2007
5	Radiotherapy 01/2021 - 09/2012
3	Stem Cell Transplantation 01/2022 - 10/2017
2	Precision Medicine 11/2022 - 01/2022
2	Transplantation 10/2020 - 06/2015
2	Immunotherapy 01/2019 - 01/2018
2	Cell Transplantation 06/2015 - 01/2012
1	Radioimmunotherapy 01/2022
1	Contraindications 01/2021
1	Organ Transplantation 01/2020
1	Salvage Therapy 01/2017
1	Treatment Delay 01/2016
1	Hematopoietic Stem Cell Transplantation 06/2015